Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Dova Pharmaceuticals, Inc. (DOVA) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/22/2019 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
11/19/2019 EFFECT Form EFFECT - Notice of Effectiveness:
11/15/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/12/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/12/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/12/2019 4 Stalfort Sean (Director) has filed a Form 4 on Dova Pharmaceuticals Inc.
Txns: Unknown transaction of 635,665 shares @ $27.5, valued at $17.5M
11/12/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/12/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/12/2019 4 Laliberte Kevin (Sr. VP, Product Development) has filed a Form 4 on Dova Pharmaceuticals Inc.
Txns: Disposed/sold 4,761 shares @ $0
Disposed/sold 115,500 options to buy @ $3.73, valued at $430.8k
Disposed/sold 24,750 options to buy @ $3.73, valued at $92.3k
Disposed/sold 50,000 options to buy @ $8.82, valued at $441k
Disposed/sold 10,000 options to buy @ $16.08, valued at $160.8k
11/12/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/12/2019 4 Hoitt Jason (Chief Commercial Officer) has filed a Form 4 on Dova Pharmaceuticals Inc.
Txns: Disposed/sold 9,970 shares @ $0
Disposed/sold 250,000 options to buy @ $6.07, valued at $1.5M
11/12/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/12/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/12/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/12/2019 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
11/12/2019 POS AM Form POS AM - Post-Effective amendments for registration statement:
11/12/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
11/12/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
11/12/2019 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
11/12/2019 8-K Quarterly results
11/12/2019 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
11/12/2019 10-Q Quarterly Report for the period ended September 30, 2019
11/01/2019 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
11/01/2019 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
10/29/2019 GN SHAREHOLDER ALERT: WeissLaw LLP Reminds DOVA, TRCB, EEI, and UCFC Shareholders About Its Ongoing Investigations
10/11/2019 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements:
10/11/2019 SC TO-T Form SC TO-T - Tender offer statement by Third Party:
10/03/2019 SC14D9C Form SC14D9C - Written communication relating to third party tender offer:
10/03/2019 8-K Quarterly results
10/02/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/02/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/02/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/02/2019 4 Hoitt Jason (Chief Commercial Officer) has filed a Form 4 on Dova Pharmaceuticals Inc.
Txns: Sold 2,387 shares @ $28, valued at $66.8k
10/02/2019 4 Laliberte Kevin (Sr. VP, Product Development) has filed a Form 4 on Dova Pharmaceuticals Inc.
Txns: Sold 3,100 shares @ $28, valued at $86.8k
Sold 596 shares @ $28, valued at $16.7k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy